Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Derrick, Deming"'
Autor:
Wayne D. Harshbarger, Derrick Deming, Gordon J. Lockbaum, Nattapol Attatippaholkun, Maliwan Kamkaew, Shurong Hou, Mohan Somasundaran, Jennifer P. Wang, Robert W. Finberg, Quan Karen Zhu, Celia A. Schiffer, Wayne A. Marasco
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Previously, a broadly neutralizing antibody, 3I14, active against groups 1 and 2 influenza A viruses was isolated from human memory B cells and showed protection in mice from lethal viral challenge. Here, Harshbarger and Deming et al. provide the cry
Externí odkaz:
https://doaj.org/article/246479680d0d43448f6a2d4b305f320c
Autor:
Benjamin Izar, Peter K. Sorger, Kai W. Wucherpfennig, Nicolo Riggi, Dirk Schadendorf, Alexander Spektor, David M. Miller, Titus J. Brinker, Shaolin Mei, Adrienne Luoma, Adam N.R. Cartwright, Meri Rogava, Kartik Subramanian, Steven Rodriguez, Nienke Moret, Derrick Deming, Sushil Kumar, Patricia Waszyk, Eugenio Morelli, Jia-Yun Chen, Clarence Yapp, Caitlin E. Mills, Sreeram Vallabhaneni, Johannes C. Melms
Video Control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3237604ff2aef693a606b4656d387ffb
https://doi.org/10.1158/0008-5472.22424536.v1
https://doi.org/10.1158/0008-5472.22424536.v1
Autor:
Benjamin Izar, Peter K. Sorger, Kai W. Wucherpfennig, Nicolo Riggi, Dirk Schadendorf, Alexander Spektor, David M. Miller, Titus J. Brinker, Shaolin Mei, Adrienne Luoma, Adam N.R. Cartwright, Meri Rogava, Kartik Subramanian, Steven Rodriguez, Nienke Moret, Derrick Deming, Sushil Kumar, Patricia Waszyk, Eugenio Morelli, Jia-Yun Chen, Clarence Yapp, Caitlin E. Mills, Sreeram Vallabhaneni, Johannes C. Melms
Suppl. F1: On-target activity and toxicity of CX-6258 Suppl. F2: On-target activity of CX-6258 and siRNA KD of Haspin Suppl. F3: Effects of CX-6258 on cell-cycle and cGAS recruitment Suppl. F4: In vivo effects of CX-6258
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43780310e141ae60c3bee4c382b66886
https://doi.org/10.1158/0008-5472.22424545.v1
https://doi.org/10.1158/0008-5472.22424545.v1
Autor:
Benjamin Izar, Peter K. Sorger, Kai W. Wucherpfennig, Nicolo Riggi, Dirk Schadendorf, Alexander Spektor, David M. Miller, Titus J. Brinker, Shaolin Mei, Adrienne Luoma, Adam N.R. Cartwright, Meri Rogava, Kartik Subramanian, Steven Rodriguez, Nienke Moret, Derrick Deming, Sushil Kumar, Patricia Waszyk, Eugenio Morelli, Jia-Yun Chen, Clarence Yapp, Caitlin E. Mills, Sreeram Vallabhaneni, Johannes C. Melms
Suppl. Table 1: Compounds used in drug screen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e33535b11bcb7c5abea9a3aea35e5f4
https://doi.org/10.1158/0008-5472.22424542
https://doi.org/10.1158/0008-5472.22424542
Autor:
Benjamin Izar, Peter K. Sorger, Kai W. Wucherpfennig, Nicolo Riggi, Dirk Schadendorf, Alexander Spektor, David M. Miller, Titus J. Brinker, Shaolin Mei, Adrienne Luoma, Adam N.R. Cartwright, Meri Rogava, Kartik Subramanian, Steven Rodriguez, Nienke Moret, Derrick Deming, Sushil Kumar, Patricia Waszyk, Eugenio Morelli, Jia-Yun Chen, Clarence Yapp, Caitlin E. Mills, Sreeram Vallabhaneni, Johannes C. Melms
Patients with melanoma resistant to RAF/MEK inhibitors (RMi) are frequently resistant to other therapies, such as immune checkpoint inhibitors (ICI), and individuals succumb to their disease. New drugs that control tumor growth and favorably modulate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2891e1ec303291c1ea2162f2b73af53b
https://doi.org/10.1158/0008-5472.c.6511807.v1
https://doi.org/10.1158/0008-5472.c.6511807.v1
Autor:
Benjamin Izar, Peter K. Sorger, Kai W. Wucherpfennig, Nicolo Riggi, Dirk Schadendorf, Alexander Spektor, David M. Miller, Titus J. Brinker, Shaolin Mei, Adrienne Luoma, Adam N.R. Cartwright, Meri Rogava, Kartik Subramanian, Steven Rodriguez, Nienke Moret, Derrick Deming, Sushil Kumar, Patricia Waszyk, Eugenio Morelli, Jia-Yun Chen, Clarence Yapp, Caitlin E. Mills, Sreeram Vallabhaneni, Johannes C. Melms
Methods and Suppl. Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1274467e9887ffe96759fa0e782083a6
https://doi.org/10.1158/0008-5472.22424548
https://doi.org/10.1158/0008-5472.22424548
Autor:
Jennifer P. Wang, Robert W. Finberg, Wayne A. Marasco, Gordon J. Lockbaum, Mohan Somasundaran, Wayne D Harshbarger, Derrick Deming, Quan Karen Zhu, Nattapol Attatippaholkun, Celia A. Schiffer, Shurong Hou, Maliwan Kamkaew
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-13 (2021)
Broadly neutralizing antibodies (bnAbs) targeting conserved influenza A virus (IAV) hemagglutinin (HA) epitopes can provide valuable information for accelerating universal vaccine designs. Here, we report structural details for heterosubtypic recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb5870d6b18ca88328d76443f6014d5
https://doaj.org/article/246479680d0d43448f6a2d4b305f320c
https://doaj.org/article/246479680d0d43448f6a2d4b305f320c
Autor:
Wayne D, Harshbarger, Derrick, Deming, Gordon J, Lockbaum, Nattapol, Attatippaholkun, Maliwan, Kamkaew, Shurong, Hou, Mohan, Somasundaran, Jennifer P, Wang, Robert W, Finberg, Quan Karen, Zhu, Celia A, Schiffer, Wayne A, Marasco
Publikováno v:
Nature Communications
Broadly neutralizing antibodies (bnAbs) targeting conserved influenza A virus (IAV) hemagglutinin (HA) epitopes can provide valuable information for accelerating universal vaccine designs. Here, we report structural details for heterosubtypic recogni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::15b9c16e91926b1dd7f0959ccce24514
https://pubmed.ncbi.nlm.nih.gov/33495478
https://pubmed.ncbi.nlm.nih.gov/33495478